Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval. [PDF]
Sims EK +13 more
europepmc +1 more source
Steroid-sparing strategies for managing immune-related adverse events. [PDF]
Huang JJ +4 more
europepmc +1 more source
Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis [PDF]
Brigitte Gubler +9 more
core +1 more source
CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion. [PDF]
Noonan J +22 more
europepmc +1 more source
Immune Checkpoint Inhibitor-Induced Concomitant Polyradiculoneuritis and Myocarditis With Positive Anti-Titin Antibodies: A Case Report and Literature Review. [PDF]
Laslandes M +5 more
europepmc +1 more source
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients [PDF]
Akinori Matsumori +30 more
core +1 more source
Background. Abatacept has been suggested to be a safe and effective drug for the treatment of rheumatoid arthritis (RA) complicated by interstitial lung disease (ILD), one of the most severe extra-articular manifestations of RA. Objectives.
Società Italiana di Reumatologia
doaj
Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis. [PDF]
Yap CF +14 more
europepmc +1 more source
Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine. [PDF]
Gaumond SI +3 more
europepmc +1 more source
Evaluating the osteoclastogenic potential of peripheral blood mononuclear cells in children with chronic nonbacterial osteomyelitis. [PDF]
Bui JP +30 more
europepmc +1 more source

